Horizons: Cancer News

September 14, 2016

Lymphoma, Leukemia, Myeloma: Hope on the Horizon

Advances in diagnosing and treating blood cancers have helped double survival rates, and the future outlook may be even brighter. Blood cancers—lymphoma, leukemia and myeloma—made up almost 10 percent of all cancer cases diagnosed in 2015, or about 162,000 new cancer cases. At the same time, progress is being made on the survival front. More […]

Read More

September 14, 2016

Simple Lifestyle Habit May Lower Risk of Ovarian Cancer

A growing body of research suggests staying active may help women reduce the risk of developing ovarian cancer. About one in 75 women will develop ovarian cancer during her lifetime, according to the American Cancer Society. In one study, researchers analyzed data from nine studies and found chronic inactivity was associated with ovarian cancer.  Compared […]

Read More

August 4, 2016

Precision Treatment: Studies Show Hope on the Horizon

The Claim:  Patients who received precision treatment—in which doctors used drugs targeting their specific DNA mutations—saw tumor shrinkage at rates six times greater than those who were given regular chemotherapy. The interval of time before their cancer continued growing was also nearly twice as long. The Study: Researchers at the University of California, San Diego Health […]

Read More

May 24, 2016

Immunotherapy: Studies Show Hope on the Horizon

The Claim: The body’s immune system can be activated to combat certain tumors—including sarcomas, cancers that occur in connective tissues—using a combination of immunotherapy and chemotherapy. The Study: In Phase I of the PembroPlus study that began in January 2015, pembrolizumab was administered to a small group of patients to evaluate its safety, determine safe […]

Read More

May 23, 2016

B-12 Deficiencies: Studies Show Hope on the Horizon

The Claim: Evaluating methylmalonic acid (MMA) and homocysteine (HC) rather than vitamin B-12 alone can better identify cancer patients with functional B-12 deficiencies. The Study: In 2014, a group of 316 patients at Cancer Treatment Centers of America® at Midwestern Regional Medical Center were tested. All patients were evaluated at baseline for vitamin B-12, methylmalonic […]

Read More

May 23, 2016

Radiation Therapy: Studies Show Hope on the Horizon

The Claim: A slightly higher dose of radiation therapy in early stage prostate cancer may reduce treatment time without compromising the outcome. The Study: A study led by a Duke Cancer Institute researcher looked at approximately 1,000 men with early stage prostate cancer that had not spread. Half of the subjects were given a traditional […]

Read More

May 23, 2016

The Missing LinQ: Technology on the Horizon

Big data gives us a mountain of facts and figures. Our challenge: putting that information to use in a way that improves patient care—now and for years to come. CancerLinQ™, a new initiative from the American Society of Clinical Oncology (ASCO), is a technology platform that allows large amounts of anonymous health care data to […]

Read More

February 19, 2016

Studies Show Hope on the Horizon

THE CLAIM: Most cancer treatments are safe for fetuses in the last two trimesters. The study: In a multicenter, case-controlled study, researchers compared 129 children whose mothers received a diagnosis of cancer during pregnancy with a control population, finding that prenatal exposure to maternal cancer—with or without treatment—did not impair cognitive, cardiac or general development […]

Read More

January 18, 2016

Cancer-Hunting Virus Could be “Game Changer” in Cancer Treatment

Most people wouldn’t intentionally want a herpes virus injected into their body, but researchers have developed a way to tweak the virus into a form that could “change the game” in cancer treatment. The herpes virus has been modified to target and kill cancer cells without harming healthy cells in a treatment called T-VEC (talimogene […]

Read More

December 21, 2015

“Liquid Biopsy” May Lead to More Targeted, Personalized Cancer Treatment

Tumor DNA provides a specific biomarker allowing cancer to be detected and tracked in patients, however retrieving that DNA using a biopsy is invasive and carries a risk of side effects. In recent years, scientists have discovered that dying tumor cells release pieces of their DNA into your bloodstream, and this circulating tumor DNA (ctDNA) […]

Read More
1 2 3 4 5 6